14 results
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
18 Dec 23
Third party tender offer statement (amended)
6:59am
, transaction costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
4 Dec 23
Third party tender offer statement (amended)
7:04am
costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
17 Nov 23
Third party tender offer statement (amended)
6:53am
costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
LLY
Lilly(Eli) & Co
15 Nov 23
Third party tender offer statement (amended)
6:51am
, transaction costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially
SC TO-T/A
EX-99
ckau3d05kx
8 Nov 23
Third party tender offer statement (amended)
5:06pm
SC TO-C
EX-99.1
e0zf3id
3 Oct 23
Information about tender offer
4:30pm
SC TO-C
765cunhfdtpg1zwfj5
3 Oct 23
Information about tender offer
4:30pm
SC14D9C
EX-2.1
ia4kw7
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-99.4
44o430 yzdqlslf7qfj
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-2.1
tg86tjc41p
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.4
y9gho8q
3 Oct 23
Tender and Support Agreement
7:35am
DEF 14A
dviggm197kaqmmz z4n
28 Apr 22
Definitive proxy
8:36am
- Prev
- 1
- Next